GE Healthcare CEO on 3Q Earnings Beat, Impact of AI

Peter Arduini, CEO of GE Healthcare, described radiopharmaceuticals as a fast-growing field that is advancing treatment and care in cancer, cardiology imaging and neurology, including Alzheimer’s-related approaches. Because these products have short half-lives and can dissipate by the end of the day, he said control of manufacturing and the supply chain is especially important. He speaks with Roma

Read the full story at Bloomberg Tech

Briefs are short summaries that point to other publishers. Read how we pick them in our Editorial Standards.